Resumo

QUAGLIATA, Valentina; ACOSTA, Agustina  e  ALVAREZ, Mariela. Use of atenolol for the treatment of infantile hemangioma: clinical case of interest. Arch. Pediatr. Urug. [online]. 2025, vol.96, n.2, e314.  Epub 01-Dez-2025. ISSN 0004-0584.  https://doi.org/10.31134/ap.96.31.

Infantile hemangiomas (IH) are the most common benign tumors of childhood. They typically appear within the first weeks of life and follow a natural course of proliferation and involution. Most IHs resolve spontaneously without intervention; however, a small number of cases with complications or located in high-risk areas may require treatment. Propranolol is the first-line therapy, but some patients experience undesirable side effects during treatment (bronchial hyperactivity, hypoglycemia, sleep disturbances). Atenolol has emerged as a therapeutic alternative with a favorable safety and efficacy profile for patients who develop adverse effects to propranolol.

We report the case of an infant with IH successfully treated with atenolol.

Palavras-chave : Hemangioma; Atenolol; Infant.

        · resumo em Português | Espanhol     · texto em Espanhol     · Espanhol ( pdf )